Literature DB >> 24082115

Damage-induced DNA replication stalling relies on MAPK-activated protein kinase 2 activity.

Frederik Köpper1, Cathrin Bierwirth, Margarete Schön, Meike Kunze, Ingegerd Elvers, Dominique Kranz, Priyanka Saini, Manoj B Menon, David Walter, Claus Storgaard Sørensen, Matthias Gaestel, Thomas Helleday, Michael P Schön, Matthias Dobbelstein.   

Abstract

DNA damage can obstruct replication forks, resulting in replicative stress. By siRNA screening, we identified kinases involved in the accumulation of phosphohistone 2AX (γH2AX) upon UV irradiation-induced replication stress. Surprisingly, the strongest reduction of phosphohistone 2AX followed knockdown of the MAP kinase-activated protein kinase 2 (MK2), a kinase currently implicated in p38 stress signaling and G2 arrest. Depletion or inhibition of MK2 also protected cells from DNA damage-induced cell death, and mice deficient for MK2 displayed decreased apoptosis in the skin upon UV irradiation. Moreover, MK2 activity was required for damage response, accumulation of ssDNA, and decreased survival when cells were treated with the nucleoside analogue gemcitabine or when the checkpoint kinase Chk1 was antagonized. By using DNA fiber assays, we found that MK2 inhibition or knockdown rescued DNA replication impaired by gemcitabine or by Chk1 inhibition. This rescue strictly depended on translesion DNA polymerases. In conclusion, instead of being an unavoidable consequence of DNA damage, alterations of replication speed and origin firing depend on MK2-mediated signaling.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24082115      PMCID: PMC3801042          DOI: 10.1073/pnas.1304355110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

1.  Chk1 promotes replication fork progression by controlling replication initiation.

Authors:  Eva Petermann; Mick Woodcock; Thomas Helleday
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-30       Impact factor: 11.205

2.  MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis.

Authors:  A Kotlyarov; A Neininger; C Schubert; R Eckert; C Birchmeier; H D Volk; M Gaestel
Journal:  Nat Cell Biol       Date:  1999-06       Impact factor: 28.824

Review 3.  Anticancer therapy with checkpoint inhibitors: what, where and when?

Authors:  Michelle D Garrett; Ian Collins
Journal:  Trends Pharmacol Sci       Date:  2011-03-30       Impact factor: 14.819

4.  An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage.

Authors:  J R Jackson; A Gilmartin; C Imburgia; J D Winkler; L A Marshall; A Roshak
Journal:  Cancer Res       Date:  2000-02-01       Impact factor: 12.701

Review 5.  Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics.

Authors:  Cynthia X Ma; James W Janetka; Helen Piwnica-Worms
Journal:  Trends Mol Med       Date:  2010-11-17       Impact factor: 11.951

6.  Regulators of cyclin-dependent kinases are crucial for maintaining genome integrity in S phase.

Authors:  Halfdan Beck; Viola Nähse; Marie Sofie Yoo Larsen; Petra Groth; Trevor Clancy; Michael Lees; Mette Jørgensen; Thomas Helleday; Randi G Syljuåsen; Claus Storgaard Sørensen
Journal:  J Cell Biol       Date:  2010-03-01       Impact factor: 10.539

7.  An ATR- and Chk1-dependent S checkpoint inhibits replicon initiation following UVC-induced DNA damage.

Authors:  Timothy P Heffernan; Dennis A Simpson; Alexandra R Frank; Alexandra N Heinloth; Richard S Paules; Marila Cordeiro-Stone; William K Kaufmann
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

8.  Structure-specific DNA endonuclease Mus81/Eme1 generates DNA damage caused by Chk1 inactivation.

Authors:  Josep V Forment; Melanie Blasius; Ilaria Guerini; Stephen P Jackson
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

9.  Wee1 controls genomic stability during replication by regulating the Mus81-Eme1 endonuclease.

Authors:  Raquel Domínguez-Kelly; Yusé Martín; Stephane Koundrioukoff; Marvin E Tanenbaum; Veronique A J Smits; René H Medema; Michelle Debatisse; Raimundo Freire
Journal:  J Cell Biol       Date:  2011-08-22       Impact factor: 10.539

10.  Activation of mammalian Chk1 during DNA replication arrest: a role for Chk1 in the intra-S phase checkpoint monitoring replication origin firing.

Authors:  C Feijoo; C Hall-Jackson; R Wu; D Jenkins; J Leitch; D M Gilbert; C Smythe
Journal:  J Cell Biol       Date:  2001-09-03       Impact factor: 10.539

View more
  33 in total

Review 1.  Exploiting replicative stress to treat cancer.

Authors:  Matthias Dobbelstein; Claus Storgaard Sørensen
Journal:  Nat Rev Drug Discov       Date:  2015-05-08       Impact factor: 84.694

2.  Chk1 loss creates replication barriers that compromise cell survival independently of excess origin firing.

Authors:  Marina A González Besteiro; Nicolás L Calzetta; Sofía M Loureiro; Martín Habif; Rémy Bétous; Marie-Jeanne Pillaire; Antonio Maffia; Simone Sabbioneda; Jean-Sébastien Hoffmann; Vanesa Gottifredi
Journal:  EMBO J       Date:  2019-07-11       Impact factor: 11.598

3.  CDKN2A/p16 Deletion in Head and Neck Cancer Cells Is Associated with CDK2 Activation, Replication Stress, and Vulnerability to CHK1 Inhibition.

Authors:  Mitchell J Frederick; Jeffrey N Myers; Mayur A Gadhikar; Jiexin Zhang; Li Shen; Xiayu Rao; Jing Wang; Mei Zhao; Nene N Kalu; Faye M Johnson; Lauren A Byers; John Heymach; Walter N Hittelman; Durga Udayakumar; Raj K Pandita; Tej K Pandita; Curtis R Pickering; Abena B Redwood; Helen Piwnica-Worms; Katharina Schlacher
Journal:  Cancer Res       Date:  2017-12-11       Impact factor: 12.701

4.  Strong antitumor synergy between DNA crosslinking and HSP90 inhibition causes massive premitotic DNA fragmentation in ovarian cancer cells.

Authors:  Daniela Kramer; Nadine Stark; Ramona Schulz-Heddergott; Norman Erytch; Shelley Edmunds; Laura Roßmann; Holger Bastians; Nicole Concin; Ute M Moll; Matthias Dobbelstein
Journal:  Cell Death Differ       Date:  2016-11-11       Impact factor: 15.828

Review 5.  Pivotal Role of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 in Inflammatory Pulmonary Diseases.

Authors:  Feng Qian; Jing Deng; Gang Wang; Richard D Ye; John W Christman
Journal:  Curr Protein Pept Sci       Date:  2016       Impact factor: 3.272

Review 6.  The fork and the kinase: a DNA replication tale from a CHK1 perspective.

Authors:  Marina A González Besteiro; Vanesa Gottifredi
Journal:  Mutat Res Rev Mutat Res       Date:  2014-10-22       Impact factor: 5.657

Review 7.  Revisiting p53 for cancer-specific chemo- and radiotherapy: ten years after.

Authors:  Jason M Beckta; Syed Farhan Ahmad; Hu Yang; Kristoffer Valerie
Journal:  Cell Cycle       Date:  2014-02-07       Impact factor: 4.534

8.  The MAPK-activated protein kinase 2 mediates gemcitabine sensitivity in pancreatic cancer cells.

Authors:  Frederik Köpper; Anna Maria Binkowski; Cathrin Bierwirth; Matthias Dobbelstein
Journal:  Cell Cycle       Date:  2014-02-21       Impact factor: 4.534

Review 9.  Targeting tumour-supportive cellular machineries in anticancer drug development.

Authors:  Matthias Dobbelstein; Ute Moll
Journal:  Nat Rev Drug Discov       Date:  2014-03       Impact factor: 84.694

10.  Combined inhibition of Aurora-A and ATR kinase results in regression of MYCN-amplified neuroblastoma.

Authors:  Isabelle Roeschert; Evon Poon; Anton G Henssen; Heathcliff Dorado Garcia; Marco Gatti; Celeste Giansanti; Yann Jamin; Carsten P Ade; Peter Gallant; Christina Schülein-Völk; Petra Beli; Mark Richards; Mathias Rosenfeldt; Matthias Altmeyer; John Anderson; Angelika Eggert; Matthias Dobbelstein; Richard Bayliss; Louis Chesler; Gabriele Büchel; Martin Eilers
Journal:  Nat Cancer       Date:  2021-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.